Moreover, c-myc/miR-150/EPG5 axis mediated dysfunction of autophagy contributes to NSCLC development, providing a potential new diagnostic and therapeutic target in NSCLC [91,92]. This evidence concerns the gene EPG5 and non-small cell lung carcinoma.